TY - JOUR
T1 - Calculations of oxygen transport by red blood cells and hemoglobin solutions in capillaries
AU - Vadapalli, Arjun
AU - Goldman, Daniel
AU - Popel, Aleksander S.
N1 - Funding Information:
This project was supported by the National Institutes of Health Grant HL-18292, American Heart Association Postdoctoral Fellow Grant, and the Johns Hopkins University Center for Advanced Transfusion Practices and Blood Research.
PY - 2002
Y1 - 2002
N2 - A theoretical model is developed to investigate the influence of hemoglobin-based oxygen carriers (HBOCs) on oxygen transport in capillary-size vessels. A discrete cell model is presented with red blood cells (RBCs) represented in their realistic parachute shape flowing in a single file through a capillary. The model includes the free and Hb-facilitated transport of O2 and Hb-O2 kinetics in the RBC and plasma, diffusion of free O2 in the suspending phase, capillary wall, interstitium and tissue. A constant tissue consumption rate is specified that drives the simultaneous release of O2 from RBC and plasma as the cells traverse the capillary. The model mainly focuses on low capillary hematocrits and studies the effect of free hemoglobin affinity, cooperativity and concentration. The results are expressed in the form of cell and capillary mass transfer coefficients, or inverse transport resistances, that relate the spatially averaged flux of O2 coming out of the RBC and capillary to a driving force for O2 diffusion. The results show that HBOCs at a concentration of 7 g/dl reduce the intracapillary transport resistance by as much as 60% when capillary hematocrit is 0.2. HBOCs with high O2 affinity unload most O2 at the venular end, while those with low affinity supply O2 at the arteriolar end. A higher cooperativity did not favor O2 delivery due to the large variation in the mass transfer coefficient values during O2 unloading. The mass transfer coefficients obtained will be used in simulations of O2 transport in complex capillary networks.
AB - A theoretical model is developed to investigate the influence of hemoglobin-based oxygen carriers (HBOCs) on oxygen transport in capillary-size vessels. A discrete cell model is presented with red blood cells (RBCs) represented in their realistic parachute shape flowing in a single file through a capillary. The model includes the free and Hb-facilitated transport of O2 and Hb-O2 kinetics in the RBC and plasma, diffusion of free O2 in the suspending phase, capillary wall, interstitium and tissue. A constant tissue consumption rate is specified that drives the simultaneous release of O2 from RBC and plasma as the cells traverse the capillary. The model mainly focuses on low capillary hematocrits and studies the effect of free hemoglobin affinity, cooperativity and concentration. The results are expressed in the form of cell and capillary mass transfer coefficients, or inverse transport resistances, that relate the spatially averaged flux of O2 coming out of the RBC and capillary to a driving force for O2 diffusion. The results show that HBOCs at a concentration of 7 g/dl reduce the intracapillary transport resistance by as much as 60% when capillary hematocrit is 0.2. HBOCs with high O2 affinity unload most O2 at the venular end, while those with low affinity supply O2 at the arteriolar end. A higher cooperativity did not favor O2 delivery due to the large variation in the mass transfer coefficient values during O2 unloading. The mass transfer coefficients obtained will be used in simulations of O2 transport in complex capillary networks.
KW - Capillaries
KW - Diffusion
KW - Hemoglobin-based oxygen carriers
KW - Microcirculation
KW - Oxygen
KW - RBC
KW - Transport
UR - http://www.scopus.com/inward/record.url?scp=0035986868&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035986868&partnerID=8YFLogxK
U2 - 10.1081/BIO-120004338
DO - 10.1081/BIO-120004338
M3 - Article
C2 - 12066873
AN - SCOPUS:0035986868
SN - 1073-1199
VL - 30
SP - 157
EP - 188
JO - Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
JF - Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
IS - 3
ER -